Oncology Institute, Inc.

The Oncology Institute, Inc. (Nasdaq: TOI) is a community-based, value-based oncology care company that became publicly traded through a 2022 business combination with DFB Healthcare Acquisitions Corp., a blank-check vehicle sponsored by DFB Healthcare that completed its own IPO in 2021. Operating in the healthcare sector, TOI delivers cancer treatment through a network of outpatient oncology clinics. The company filed an 8-K with the Securities and Exchange Commission on June 18, 2026, disclosing a material corporate event to investors. TOI remains listed on Nasdaq following its SPAC-backed debut. Sign up at SpacDesk for full filing data, analytics, and real-time coverage of TOI and the broader SPAC universe.